Q&A With Covington's Mark Lynch

Law360, New York (May 9, 2012, 2:55 PM EDT) -- Mark Lynch is a partner in Covington & Burling LLP's Washington, D.C., office and co-chairman of the firm's Pharmaceutical Litigation and Government Investigations Group, which includes over 150 lawyers engaged in government investigations and False Claims Act, product liability, consumer fraud, intellectual property, antitrust, commercial and administrative litigation for innovator life sciences companies. This practice is closely integrated with Covington’s FDA regulatory practice.

In addition to coordinating the firm’s pharmaceutical litigation practice, Lynch has represented GlaxoSmithKline in the Average Wholesale Price litigation for over a decade...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.